Are you Dr. Ruprecht?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
Dana-Farber Cancer Institute, Jfb 809
Boston, MA 02115Phone+1 617-632-3719Fax+1 617-632-3112
Summary
- Dr. Ruth Ruprecht, MD is an oncologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts and California. She is affiliated with Dana-Farber Cancer Institute and is a Professor of Medicine at Dana-Farber Cancer Institute.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1982 - 1983
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1980 - 1982- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1977 - 1980
University of Miami Leonard M. Miller School of MedicineClass of 1977
Certifications & Licensure
CA State Medical License 1978 - 2018
MA State Medical License 1984 - 2015
Publications & Presentations
PubMed
- 5 citationsMucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection.Bishal Marasini, Hemant K. Vyas, Samir K. Lakhashe, Dinesh Hariraju, Akil Akhtar
AIDS. 2021-08-16 - 8 citationsPET/CT targeted tissue sampling reveals virus specific dIgA can alter the distribution and localization of HIV after rectal exposure.Roslyn A. Taylor, Sixia Xiao, Ann M. Carias, Michael D. McRaven, Divya N. Thakkar
Plos Pathogens. 2021-06-01 - 4 citationsModified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge.Delphine C. Malherbe, Lo Vang, Jason Mendy, Philip Barnette, David A. Spencer
Frontiers in Immunology. 2021-02-15
Press Mentions
Adjuvanted HIV-1 Vaccine Promotes Antibody-Dependent Phagocytic Responses and Protects Against Heterologous SHIV ChallengeSeptember 3rd, 2020
Mymetics Receives Funding from NIH for Novel HIV Vaccine StudyApril 29th, 2019
Evidence for Persistence of the SHIV Reservoir Early After MHC Haploidentical Hematopoietic Stem Cell TransplantationOctober 25th, 2018- Join now to see all
Grant Support
- Infant Immunoprophylaxis Against A Primate LentivirusNational Institute Of Allergy And Infectious Diseases2003–2012
- Neutralizing Antibody Coverage For CTL Vaccines (Project 2)National Center For Research Resources2010–2011
- Small Animal ContainmentNational Institute Of Allergy And Infectious Diseases2009–2011
- HIV-1 Microglial Tropism And NeurovirulenceNational Center For Research Resources2009–2011
- Molecular BiologyNational Institute Of Allergy And Infectious Diseases2008–2011
- Administrative CoreNational Institute Of Allergy And Infectious Diseases2008–2011
- Vaccination Against Mucosal HIV Clade C TransmissionNational Institute Of Allergy And Infectious Diseases2007–2011
- Harnessing Humoral Immunity Against HIV Clade CNational Institute Of Allergy And Infectious Diseases2007–2011
- SHIV Transmission Through Oral VS Other MucosaeNational Center For Research Resources2005–2011
- Attenuated Recombinant Listeria As Oral AIDS VaccineNational Center For Research Resources2004–2011
- Molecular Evolution Of Multiply Deleted SIV In VivoNational Center For Research Resources2003–2011
- Infant Immunoprophylaxis Against A Primate LentivirusNational Center For Research Resources2003–2011
- Attenuated Listeria Vectors As An AIDS Vaccine In MacaquesNational Institute Of Allergy And Infectious Diseases2009
- HIV-1 ENV Microglial Tropism And NeurovirulenceNational Institute Of Neurological Disorders And Stroke2008–2009
- Vaccination Against Intrapartum HIV-1 Clade C TransmissionNational Center For Research Resources2003–2009
- Mechanisms Of Oral SIV TransmissionNational Center For Research Resources2003–2008
- Molecular Evolution Of Multiply Deleted SIV In VivoNational Center For Research Resources1999–2008
- Administrative SupportNational Institute Of Allergy And Infectious Diseases2007
- SHIV Transmission Through Oral Versus Other MucosaeNational Institute Of Dental &Craniofacial Research2004–2007
- HIV VaccinesNational Institute Of Allergy And Infectious Diseases2006
- Vaccination Against Intrapartum HIV Clade C TransmissionNational Institute Of Allergy And Infectious Diseases2000–2006
- Dynamics Of SHIV Clade C And S Mansoni CoinfectionNational Institute Of Allergy And Infectious Diseases2005
- Vaccination Against Intrapartum HIV1 Cladec TransmissionNational Center For Research Resources2004
- Molecular Evolution Of Multiple Deleted SIV In VivoNational Center For Research Resources2004
- Attenuated Recombinant Listeria As Oral AIDS VaccineNational Institute Of Allergy And Infectious Diseases2003
- Towards An Oral AIDS VaccineNational Center For Research Resources2003
- Mechanisms Of Oral SIV TransmissionNational Institute Of Dental &Craniofacial Research1999–2003
- Fetal Immunoprophylaxis Against Primate LentivirusNational Center For Research Resources1999–2003
- Passive Immunization With Synergistic Human MabsNational Institute Of Allergy And Infectious Diseases2000–2002
- Core--Animal Biohazard FacilityNational Institute Of Allergy And Infectious Diseases1999–2002
- REV Independent Sivmac239 Infection In Newborn MacaquesNational Center For Research Resources1999–2002
- Immunotherapy Of Congenital SIV InfectionNational Center For Research Resources1999–2002
- Lentivirus Infection Of Neonatal Dendritic CellsNational Institute Of Allergy And Infectious Diseases1998–2002
- Vaccination Against Mucosal SIV Infection In NeonatesNational Center For Research Resources1997–2002
- Fetal Immunoprophylaxis Against A Primate LentivirusNational Institute Of Allergy And Infectious Diseases1997–2001
- SIV &Hiv Pathogenesis During OntogenyNational Center For Research Resources2000
- Vaccination Against Intrapartum HIV Clade C TransmissionNational Institute Of Allergy And Infectious Diseases1999
- Core--Animal BiohazardNational Institute Of Allergy And Infectious Diseases1996–1998
- SIV And HIV Pathogenesis During OntogenyNational Institute Of Allergy And Infectious Diseases1995–1998
- Vaccination Against Mucosal SIV Infection In NeonatesNational Institute Of Allergy And Infectious Diseases1994–1998
- Rev-Independent Sivmac 239 Infection In Newborn MacaquesNational Institute Of Allergy And Infectious Diseases1997
- Immunotherapy Of Congenital SIV Infection:VaccineNational Center For Research Resources1997
- Fetal Immunoprophylaxis Against A LentivirusNational Institute Of Allergy And Infectious Diseases1994–1996
- SIV Pathogenesis During OntogenyNational Institute Of Allergy And Infectious Diseases1991–1994
- Isolation And Characterization Of Rodent LentivirusesNational Institute Of Allergy And Infectious Diseases1990–1992
- Biological Response Modifiers As Therapies For AIDSNational Institute Of Allergy And Infectious Diseases1987–1991
Professional Memberships
- Member
